Literature DB >> 23235213

Re: Increased survival with enzalutamide in prostate cancer after chemotherapy.

Samir S Taneja.   

Abstract

Entities:  

Year:  2012        PMID： 23235213     DOI： 10.1016/j.juro.2012.10.050

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  3 in total

1.  scdNet: a computational tool for single-cell differential network analysis.

Authors:  Yu-Chiao Chiu; Tzu-Hung Hsiao; Li-Ju Wang; Yidong Chen; Yu-Hsuan Joni Shao
Journal:  BMC Syst Biol       Date:  2018-12-21

2.  Drivers of AR indifferent anti-androgen resistance in prostate cancer cells.

Authors:  Florian Handle; Stefan Prekovic; Christine Helsen; Thomas Van den Broeck; Elien Smeets; Lisa Moris; Roy Eerlings; Sarah El Kharraz; Alfonso Urbanucci; Ian G Mills; Steven Joniau; Gerhardt Attard; Frank Claessens
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

3.  Design, synthesis and evaluation of novel enzalutamide analogues as potential anticancer agents.

Authors:  Ritesh P Bhole; Rupesh V Chikhale; Ravindra D Wavhale; Fatmah Ali Asmary; Tahani Mazyad Almutairi; Hassna Mohammed Alhajri; Chandrakant G Bonde
Journal:  Heliyon       Date:  2021-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.